TCL Archive In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named June 5, 1981
TCL Archive Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer October 25, 2013